Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Stevanato Group S.P.A. (STVN)

Stevanato Group S.P.A. (STVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,393,336
  • Shares Outstanding, K 295,540
  • Annual Sales, $ 1,175 M
  • Annual Income, $ 157,620 K
  • 60-Month Beta 0.70
  • Price/Sales 6.53
  • Price/Cash Flow 33.93
  • Price/Book 6.98
Trade STVN with:

Options Overview Details

View History
  • Implied Volatility 54.52% ( -2.94%)
  • Historical Volatility 43.49%
  • IV Percentile 51%
  • IV Rank 54.97%
  • IV High 82.03% on 11/02/23
  • IV Low 20.93% on 04/20/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 20
  • Volume Avg (30-Day) 13
  • Put/Call OI Ratio 0.74
  • Today's Open Interest 155
  • Open Int (30-Day) 202

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate 0.12
  • Number of Estimates 4
  • High Estimate 0.12
  • Low Estimate 0.11
  • Prior Year 0.12
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.52 +7.76%
on 03/21/24
33.49 -17.89%
on 03/27/24
-1.67 (-5.73%)
since 03/19/24
3-Month
25.52 +7.76%
on 03/21/24
34.73 -20.82%
on 02/07/24
-0.84 (-2.96%)
since 01/19/24
52-Week
23.00 +19.57%
on 11/01/23
36.30 -24.24%
on 08/09/23
+0.79 (+2.96%)
since 04/19/23

Most Recent Stories

More News
Global Medical Device Packaging Market Size Expected to Reach $50 Billion By 2028

EQNX::TICKER_START (NASDAQ:STSS),(NYSE:STVN),(NYSE:WST),(NYSE:BDX),(NYSE:PFE) EQNX::TICKER_END

STSS : 0.2849 (-8.10%)
STVN : 26.59 (-6.37%)
WST : 372.97 (-1.16%)
BDX : 233.36 (+0.09%)
PFE : 25.97 (+2.28%)
Stevanato Group (STVN) Q1 Earnings Lag Estimates

Stevanato (STVN) delivered earnings and revenue surprises of -7.69% and 1.80%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

STVN : 26.59 (-6.37%)
ESPR : 1.9350 (+3.48%)
Stevanato Group Reports First Quarter 2023 Financial Results

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced...

STVN : 26.59 (-6.37%)
Stevanato Group to Present at BofA Securities Healthcare Conference

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced...

STVN : 26.59 (-6.37%)
Will Akebia Therapeutics (AKBA) Report Negative Q1 Earnings? What You Should Know

Akebia Therapeutics (AKBA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AKBA : 1.3350 (-3.96%)
STVN : 26.59 (-6.37%)
Stevanato Group S.p.A. (STVN) Hit a 52 Week High, Can the Run Continue?

Stevanato (STVN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

STVN : 26.59 (-6.37%)
Stevanato Group to Report First Quarter 2023 Financial Results on May 4, 2023

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced...

STVN : 26.59 (-6.37%)
Here's Why You Should Hold Teladoc Health (TDOC) Stock Now

Teladoc Health (TDOC) remains well-poised for growth on the back of solid revenues, sustained demand for virtual care services and sufficient cash-generating abilities.

MASI : 134.64 (-0.94%)
TDOC : 12.89 (-2.20%)
LIVN : 51.89 (-1.65%)
STVN : 26.59 (-6.37%)
Stevanato Group S.p.A. (STVN) Hits Fresh High: Is There Still Room to Run?

Stevanato (STVN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

STVN : 26.59 (-6.37%)
CPRX : 15.29 (-0.33%)
Stevanato Group Collaborates with Thermo Fisher Scientific to Bring its Innovative On-Body Delivery System Platform to Market

Stevanato Group S.p.A. (NYSE: STVN) a leading global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today its collaboration...

STVN : 26.59 (-6.37%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Stevanato Group S.p.A. is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. Stevanato Group S.p.A. is based in PIOMBINO DESE, Italy.

See More

Key Turning Points

3rd Resistance Point 31.04
2nd Resistance Point 30.08
1st Resistance Point 29.24
Last Price 26.59
1st Support Level 27.43
2nd Support Level 26.47
3rd Support Level 25.63

See More

52-Week High 36.30
Fibonacci 61.8% 31.22
Fibonacci 50% 29.65
Fibonacci 38.2% 28.08
Last Price 26.59
52-Week Low 23.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar